07.31.26 -- Modulating Multispecific Manufacturability With AP Biosciences' JJ You, Ph.D.

Drug development demands scientific depth and operational precision. Explore how efficiency can be built into discovery and manufacturing, as well as why cost‑sensitive innovation is crucial.

Flexible development and manufacturing are essential for complex biologics. Examine scalable processes, advanced cell line strategies, and partnership models that move programs efficiently.

Advance potent drug manufacturing through tighter containment, thoughtful process engineering, and closed handling that protects workers while improving efficiency and scale.

See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

Upgrade sterility validation protocols by pairing quantitative enzyme indicators with biological indicators to reduce equipment downtime and confidently verify decontamination cycle efficacy. 

Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.

Discover how knowledge of microbial processes and process characterization understanding can be used to design targeted BLA programs while managing risks.

Learn key considerations for qualifying GMP raw materials in cell and gene therapy manufacturing, emphasizing quality control, supplier selection, and regulatory compliance to ensure safety.

With each batch of cell and gene therapy product representing a wealth of lifesaving potential, this biopharma company needed the right packaging solution for its relatively new therapy applications.